SNDL INC (SNDL) Fundamental Analysis & Valuation

NASDAQ:SNDL • CA83307B1013

1.51 USD
-0.02 (-1.31%)
At close: Mar 6, 2026
1.5 USD
-0.01 (-0.66%)
After Hours: 3/6/2026, 8:00:02 PM

This SNDL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

SNDL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. While SNDL seems to be doing ok healthwise, there are quite some concerns on its profitability. SNDL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. SNDL Profitability Analysis

1.1 Basic Checks

  • SNDL had negative earnings in the past year.
  • SNDL had a positive operating cash flow in the past year.
  • In the past 5 years SNDL always reported negative net income.
  • SNDL had negative operating cash flow in 4 of the past 5 years.
SNDL Yearly Net Income VS EBIT VS OCF VS FCFSNDL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

  • SNDL has a better Return On Assets (-7.00%) than 72.54% of its industry peers.
  • SNDL's Return On Equity of -8.39% is fine compared to the rest of the industry. SNDL outperforms 76.68% of its industry peers.
Industry RankSector Rank
ROA -7%
ROE -8.39%
ROIC N/A
ROA(3y)-13.41%
ROA(5y)-27.04%
ROE(3y)-16.09%
ROE(5y)-30.65%
ROIC(3y)N/A
ROIC(5y)N/A
SNDL Yearly ROA, ROE, ROICSNDL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • The Gross Margin of SNDL (27.03%) is comparable to the rest of the industry.
  • SNDL's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SNDL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y38.61%
GM growth 5Y-0.23%
SNDL Yearly Profit, Operating, Gross MarginsSNDL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

6

2. SNDL Health Analysis

2.1 Basic Checks

  • SNDL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SNDL has about the same amount of shares outstanding.
  • The number of shares outstanding for SNDL has been increased compared to 5 years ago.
  • Compared to 1 year ago, SNDL has an improved debt to assets ratio.
SNDL Yearly Shares OutstandingSNDL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SNDL Yearly Total Debt VS Total AssetsSNDL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.09, we must say that SNDL is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.09, SNDL perfoms like the industry average, outperforming 56.99% of the companies in the same industry.
  • The Debt to FCF ratio of SNDL is 2.69, which is a good value as it means it would take SNDL, 2.69 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 2.69, SNDL belongs to the best of the industry, outperforming 92.75% of the companies in the same industry.
  • SNDL has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • SNDL has a Debt to Equity ratio (0.11) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 2.69
Altman-Z 1.09
ROIC/WACCN/A
WACC8.43%
SNDL Yearly LT Debt VS Equity VS FCFSNDL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 5.04 indicates that SNDL has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 5.04, SNDL is in the better half of the industry, outperforming 64.77% of the companies in the same industry.
  • A Quick Ratio of 3.54 indicates that SNDL has no problem at all paying its short term obligations.
  • With a Quick ratio value of 3.54, SNDL perfoms like the industry average, outperforming 57.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.04
Quick Ratio 3.54
SNDL Yearly Current Assets VS Current LiabilitesSNDL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. SNDL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.68% over the past year.
  • The Revenue has been growing slightly by 4.43% in the past year.
  • The Revenue has been growing by 70.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.59%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y154.1%
Revenue growth 5Y70.65%
Sales Q2Q%5.35%

3.2 Future

  • SNDL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.75% yearly.
  • The Revenue is expected to grow by 3.24% on average over the next years.
EPS Next Y51.52%
EPS Next 2Y43.55%
EPS Next 3Y33.21%
EPS Next 5Y42.75%
Revenue Next Year4.28%
Revenue Next 2Y3.84%
Revenue Next 3Y3.42%
Revenue Next 5Y3.24%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SNDL Yearly Revenue VS EstimatesSNDL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
SNDL Yearly EPS VS EstimatesSNDL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -5 -10 -15

4

4. SNDL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SNDL. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 201.68 indicates a quite expensive valuation of SNDL.
  • 68.91% of the companies in the same industry are more expensive than SNDL, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of SNDL to the average of the S&P500 Index (24.57), we can say SNDL is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 201.68
SNDL Price Earnings VS Forward Price EarningsSNDL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 150 200

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SNDL is valued cheaper than 89.12% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SNDL indicates a rather cheap valuation: SNDL is cheaper than 91.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.2
EV/EBITDA 9.95
SNDL Per share dataSNDL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • SNDL's earnings are expected to grow with 33.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.55%
EPS Next 3Y33.21%

0

5. SNDL Dividend Analysis

5.1 Amount

  • SNDL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SNDL Fundamentals: All Metrics, Ratios and Statistics

SNDL INC

NASDAQ:SNDL (3/6/2026, 8:00:02 PM)

After market: 1.5 -0.01 (-0.66%)

1.51

-0.02 (-1.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-04
Earnings (Next)03-12
Inst Owners23.38%
Inst Owner Change1.56%
Ins Owners5.96%
Ins Owner ChangeN/A
Market Cap388.67M
Revenue(TTM)951.58M
Net Income(TTM)-92.28M
Analysts82.5
Price Target5.71 (278.15%)
Short Float %0.62%
Short Ratio0.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.83%
Min EPS beat(2)-83.95%
Max EPS beat(2)119.61%
EPS beat(4)3
Avg EPS beat(4)111%
Min EPS beat(4)-83.95%
Max EPS beat(4)345.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.86%
Min Revenue beat(2)0.07%
Max Revenue beat(2)3.66%
Revenue beat(4)3
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-6.38%
Max Revenue beat(4)3.66%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-166.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 201.68
P/S 0.56
P/FCF 9.2
P/OCF 7.59
P/B 0.48
P/tB 0.58
EV/EBITDA 9.95
EPS(TTM)-0.02
EYN/A
EPS(NY)0.01
Fwd EY0.5%
FCF(TTM)0.16
FCFY10.87%
OCF(TTM)0.2
OCFY13.17%
SpS2.71
BVpS3.13
TBVpS2.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7%
ROE -8.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.03%
FCFM 6.05%
ROA(3y)-13.41%
ROA(5y)-27.04%
ROE(3y)-16.09%
ROE(5y)-30.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y38.61%
GM growth 5Y-0.23%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 2.69
Debt/EBITDA 2.69
Cap/Depr 21.63%
Cap/Sales 1.28%
Interest Coverage N/A
Cash Conversion 156.16%
Profit Quality N/A
Current Ratio 5.04
Quick Ratio 3.54
Altman-Z 1.09
F-Score6
WACC8.43%
ROIC/WACCN/A
Cap/Depr(3y)18.2%
Cap/Depr(5y)23.85%
Cap/Sales(3y)1.2%
Cap/Sales(5y)3.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.59%
EPS Next Y51.52%
EPS Next 2Y43.55%
EPS Next 3Y33.21%
EPS Next 5Y42.75%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y154.1%
Revenue growth 5Y70.65%
Sales Q2Q%5.35%
Revenue Next Year4.28%
Revenue Next 2Y3.84%
Revenue Next 3Y3.42%
Revenue Next 5Y3.24%
EBIT growth 1Y73.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year657.88%
EBIT Next 3Y150.28%
EBIT Next 5Y93%
FCF growth 1Y604.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4779.4%
OCF growth 3YN/A
OCF growth 5YN/A

SNDL INC / SNDL FAQ

What is the ChartMill fundamental rating of SNDL INC (SNDL) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SNDL.


Can you provide the valuation status for SNDL INC?

ChartMill assigns a valuation rating of 4 / 10 to SNDL INC (SNDL). This can be considered as Fairly Valued.


What is the profitability of SNDL stock?

SNDL INC (SNDL) has a profitability rating of 2 / 10.


Can you provide the financial health for SNDL stock?

The financial health rating of SNDL INC (SNDL) is 6 / 10.